GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Basilea Pharmaceutica Ltd (XSWX:BSLN) » Definitions » ROE % Adjusted to Book Value

Basilea Pharmaceutica (XSWX:BSLN) ROE % Adjusted to Book Value : 0.00% (As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Basilea Pharmaceutica ROE % Adjusted to Book Value?

Basilea Pharmaceutica's ROE % for the quarter that ended in Dec. 2023 was -1,715.58%. Basilea Pharmaceutica's PB Ratio for the quarter that ended in Dec. 2023 was N/A. Basilea Pharmaceutica's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was N/A.


Basilea Pharmaceutica ROE % Adjusted to Book Value Historical Data

The historical data trend for Basilea Pharmaceutica's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Basilea Pharmaceutica ROE % Adjusted to Book Value Chart

Basilea Pharmaceutica Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - Negative Equity Negative Equity

Basilea Pharmaceutica Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Negative Equity - Negative Equity Negative Equity -

Competitive Comparison of Basilea Pharmaceutica's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Basilea Pharmaceutica's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Basilea Pharmaceutica's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Basilea Pharmaceutica's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Basilea Pharmaceutica's ROE % Adjusted to Book Value falls into.



Basilea Pharmaceutica ROE % Adjusted to Book Value Calculation

Basilea Pharmaceutica's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=Negative Equity / N/A
=Negative Equity

Basilea Pharmaceutica's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-1,715.58% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Basilea Pharmaceutica ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Basilea Pharmaceutica's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Basilea Pharmaceutica (XSWX:BSLN) Business Description

Traded in Other Exchanges
Address
Switzerland Innovation Park, Basel Area, Main Campus, Near Basel, Allschwil, CHE, 4058
Basilea Pharmaceutica Ltd is a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing drugs to meet the needs of patients with severe bacterial and fungal infections. The Company has operating subsidiaries in the United Kingdom and Germany. Geographically company derives revenue from Japan, Ireland, Republic of Korea, USA, Uruguay, Sweden, Canada, Jordan, Switzerland and Other countries.

Basilea Pharmaceutica (XSWX:BSLN) Headlines

No Headlines